We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Information for patients, healthcare professionals and developers of new medicines
Explore the impact of parental conflict on children and young people.
Advises on how to consider light within the planning system.
There have been very rare reports of posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS) with pseudoephedrine.
Whether you’re a patient, healthcare professional or carer, this year’s #MedSafetyWeek campaign is calling on you to help improve the safety of medical products by reporting any suspected side effects and adverse incidents to the MHRA Yellow Card scheme.
Check what side effects people have reported when they've taken a medicine.
Systemic fluoroquinolones must now only be prescribed when other commonly recommended antibiotics are inappropriate. This follows a review by the MHRA which looked at the effectiveness of current measures to reduce the identified risk of disabling and potentially long-lasting or...
A cross-sectional study on the protective role of parental monitoring, religiosity, and self-esteem
Explainer for the pharmaceutical industry on Pharmacovigilance requirements mitigations to bridge the gap between the implementation of the EU Regulation on veterinary medicines and the revised Veterinary Medicines Regulations as they have an effect in Great Britain (GB VMR).
How the maritime industry should treat waste at sea and in ports, reduce oil and air pollution, and control ozone-depleting substances.
Change your protocol, update your authorisation, report safety issues, submit safety updates and complete your end-of-trial study report.
How to use an interrupted time series to evaluate your digital health product.
Forms for the notification of serious undesirable effects (SUEs) from cosmetic products in Great Britain.
The Yellow Card Biobank will today start investigating a new group of medicines known as Direct Oral Anticoagulants
Find out about the long-term effects some people can have after having COVID-19.
Who you should contact if a pet or other animal or human has an unexpected reaction to a veterinary medicine or a problem with a microchip
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.